Dipartimento di Medicina interna e terapia medica

Contenuti del sito

Menu di navigazione - Torna all'inizio


Contenuto della pagina - Torna all'inizio


Alessandro Pecci

Ricercatore Confermato
Sede:
Unità di Clinica Medica, Trombosi ed emostasi, ematologia dell'anziano -  c/o Policlinico San Matteo
Telefono+ 39 0382 526284
Fax+ 39 0382 526223
E-mailalessandro.pecci@unipv.it
CurriculumCURRICULUM PECCI
PubblicazioniPecci A, Malara A, Badalucco S, Bozzi V, Torti M, Balduini CL, Balduini A. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation. Thromb Haemost 2009; 102:90-6. -
Savoia A, De Rocco D, Panza E, Bozzi V, Scandellari R, Loffredo G, Mumford A, Heller PG, Noris P, De Groot MR, Giani M, Freddi P, Scognamiglio F, Riondino S, Pujol-Moix N, Fabris F, Seri M, Balduini CL, Pecci A. Heavy chain myosin-9-related disease (MYH9-related disease): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. Thromb Haemost 2010; 103:826-32. -
Pecci A, Gresele P, Klersy C, Savoia A, Noris P, Fierro T, Bozzi V, Mezzasoma AM, Melazzini F, Balduini CL. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations. Blood 2010; 116:5832-7. -
Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Brit J Haematol 2011; 154:161-74. -
Pecci A, Bozzi V, Panza E, Barozzi S, Gruppi C, Seri M, Balduini CL. Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells. Thromb Haemost 2011; 106:693-704. -
Pecci A, Biino G, Fierro T, Bozzi V, Mezzasoma AM, Noris P, Ramenghi U, Loffredo G, Fabris F, Momi S, Magrini U, Pirastu M, Savoia A, Balduini CL, Gresele P. Alteration of liver enzymes is a feature of the MYH9-related disease syndrome. PLoS One 2012; 7(4):e35986. -
Necchi V, Balduini A, Noris P, Barozzi S, Sommi P, di Buduo C, Balduini CL, Solcia E, Pecci A. Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombocytopenia. Thromb Haemost 2013; 109:263-71. -
Pecci A. Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin receptor agonists. Int J Hematol 2013; 98:34-47. -
Pecci A, Klersy C, Gresele P, Lee KJD, De Rocco D, Bozzi V, Russo G, Heller PG, Loffredo G, Ballmaier M, Fabris F, Beggiato E, Kahr WHA, Pujol-Moix N, Platokouki H, Van Geet C, Noris P, Yerram P, Hermans C, Gerber B, Economou M, De Groot M, Zieger B, De Candia E, Fraticelli V, Kersseboom R, Piccoli GB, Zimmermann S, Fierro T, Glembotsky AC, Vianello F, Zaninetti C, Nicchia E, Güthner C, Baronci C, Seri M, Knight PJ, Balduini CL, Savoia A. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. Hum Mutat 2014; 35: 236-47. -
Pecci A, Balduini CL. Lessons in platelet production from inherited thrombocytopenias. Br J Haematol 2014; 165:179-92.